NCT05556473View on ClinicalTrials.gov

F-Tryptophan PET/CT in Human Cancers

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Intracranial GliomaMetastatic Brain TumorBreast CancerNeuroendocrine TumorsRectal Cancer
Interventions
DRUG

1-(2-[18F]FLUOROETHYL)-L-Tryptophan

Radioactive tracer 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan 0.14mCi/kg/5MBq/kg injection given one time prior to PET Scan.

Trial Locations (1)

48201

RECRUITING

Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

Washington University School of Medicine

OTHER

lead

Barbara Ann Karmanos Cancer Institute

OTHER